Company attributes
Other attributes
Renew Biopharma is a Delaware C Corporation based in San Diego, California, that was founded in 2017 by Michael Mendez. Michael Mendez is also the CEO of Renew BioPharma with more than 20 years of experience working in the synthetic biology industry. The company is focused on creating a pipeline of 100 percent pure, uncontaminated and non-psychoactive cannabinoids in quantities large enough to enable human therapeutic treatments. Renew uses molecular biology and pathway engineering instead of using agriculturally-grown Cannabis plants. Renew has a proprietary family of pharmacological chemical compounds - cannabinoids - specifically pure forms of CBG (cannabigerol) and CBD (cannabidiol). Renew's intellectual property includes both specific genes in the biosynthesis of cannabinoids and the ability to engineer a synthetic cannabinoid pathway into microorganisms, including microalgae.
Renew BioPharma possesses intellectual property and technological capabilities related to engineering enzymes for creating proprietary derivative molecules for the development of pharmaceutical drugs.
